Middle East & Africa Cell Counting Market Research Report – Segmented By Product, Consumables, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Size, Share, Trends, Growth, Forecast | 2024 to 2029

Updated On: January, 2024
ID: 5772
Pages: 145

Middle East & Africa Cell Counting Market Size & Growth (2023 to 2028)

The MEA Cell Counting Market Size is valued at USD 0.09 billion in 2023 and is predicted to reach USD 0.12 billion by 2028, growing at a CAGR of 5.16% during the forecast period 2023 to 2028.

The growing investments in cell-based research drive the MEA cell counting market growth during the forecast period. Cell counting is a crucial process used in life science, medical diagnosis, and treatment, with widespread application in research and clinical practice. For instance, complete blood count aids physicians in diagnosing illnesses and determining personalized treatment plans by analyzing the concentration of various blood cells, such as red blood cells and white blood cells. Cell counting is essential in biological experiments, where researchers need accurate cell counts before cell culture or downstream analysis. Methods such as hemocytometers and automated cell counters are commonly employed for this purpose, with approximately 71% of researchers using hemocytometers for cell counting.

The rising prevalence of chronic diseases and chronic infections across the MEA further fuels the growth rate of the MEA cell counting market. In Egypt, nearly 70 percent of deaths are attributed to chronic diseases, affecting individuals with conditions like autoimmune disorders, cancer and cardiovascular disease, often leading to anemia caused by reduced red blood cell counts. Cell counting techniques are essential in the treatment process, as they enable the identification of low, abnormal or high cell counts, signifying various changes in the body, such as a high white cell count indicating infection.

The growing number of advancements in cell counting technology contributes to the growth of the MEA cell counting market. Researchers and manufacturers are actively developing solutions for accurate cell counting, minimizing counting errors. Manufacturers also focus on creating diverse devices to facilitate cell counting technology. The support from the governments of MEA countries and investments from public and private organizations further fuels the market progress. The approval of novel cell counting techniques enhances the MEA cell counting market growth.

The high cost of cell analysis primarily hampers the growth of the MEA cell counting market. Factors such as inadequate infrastructure facilities, a shortage of skilled professionals and strict regulatory requirements further impede the North American market growth. Cell counting also faces challenges, such as manual counting errors, inconsistency in live or dead cell counts, lack of standardized protocols, recording and monitoring issues in lab journals, and difficulty in implementing validation processes.

This research report on the Middle East & Africa Cell Counting Market has been segmented and sub-segmented into the following categories.

By Product:

  • Instruments
  • Cell Counters
  • Hematology Analysers
  • Spectrophotometer
  • Flow Cytometer
  • Hemocytometer
  • Others

By Consumables:

  • Microplates
  • Reagent
  • Assay Kits

By End User:

  • Pharmaceutical & Biotechnology Industries
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes

By Country:

  • KSA
  • UAE
  • Israel
  • the rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The Middle East and Africa region accounted for a moderate share of the global market in 2023 and is expected to grow steadily during the forecast period due to the growing focus of international key market participants and increased investment in healthcare research. Cell counting plays a crucial role in manufacturing therapeutic drug products, ensuring drug efficacy remains unaffected by cell viability concentrations within samples. Government initiatives to launch advanced cell counting methods further enhance their applications in healthcare. UAE is expected to hold a substantial share of the MEA market during the forecast period due to numerous laboratories and the growing number of mergers and acquisitions. The prevalence of chronic infections like AIDS and HIV also fuels market growth in UAE. Saudi Arabia is estimated to register a healthy CAGR in the coming years due to the growing number of clinical trial centers and pharmaceutical companies. Rising awareness about pre-diagnosis among the population and the emergence of new types of infections further drive the Saudi Arabian market growth


Noteworthy Companies dominating the Middle East & Africa Cell Counting Market are Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, Inc., GE Healthcare, Becton, Dickinson and Company, and PerkinElmer, Inc.,

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample